Back to BARCLAYS PLC BARCLAYS PLC

JANXJANX
Showing 8 of 18 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in JANUX THERAPEUTICS INC

BARCLAYS PLC holds 63,679 shares of JANX (JANUX THERAPEUTICS INC), worth $978,110 as of 2026-Q2. The position was increased (+13.7% shares). JANX represents 0.0% of BARCLAYS PLC's portfolio.

Current Value

$978,110

Current Shares

63,679

Total Value Change

-$6.9M

Total Shares Change

-110,382

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
63,679
+13.7%
$978,1100.0%$15.36
28
2026-Q1
Decreased
55,988
-74.7%
$778,2320.0%$13.44
0
2025-Q4
Increased
221,233
+53.6%
$3.1M0.0%$13.83
37
2025-Q3
Increased
144,024
+8.8%
$3.5M0.0%$23.70
29
2025-Q2
Increased
132,341
+95.3%
$3.1M0.0%$23.15
42
2025-Q1
Decreased
67,766
-74.3%
$1.8M0.0%$29.10
0
2024-Q4
Increased
263,970
+51.6%
$14.1M0.0%$52.50
39
2024-Q3
Increased
174,061
+496.6%
$7.9M0.0%$46.25
44

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used